Literature DB >> 31703790

Pain without inflammation in rheumatic diseases.

Jon Lampa1.   

Abstract

Chronic pain is a common symptom in rheumatic diseases, and the patient with pain and no signs of inflammation poses a challenge to the physician. Notably, all rheumatic diseases have components of non-inflammatory pain and a higher prevalence of fibromyalgia compared to the overall population. Hypothetically, a chronic pain stimulus may have stronger impact in a chronic inflammatory state, and the process towards a pain condition may be influenced by individual predisposition for development of chronic pain. In addition, the features of peripheral and central pain processing may be exacerbated by inflammation, and disturbed pain processing may be a feature contributing to widespread pain. We herein review and describe the prevalence of chronic pain and different pain modalities in the most common rheumatic diseases. In addition, the background mechanisms of non-inflammatory pain in rheumatic diseases are discussed. Finally, we here review the current strategies for pain management, with a special focus on non-inflammatory pain. The key message is that pain management should be individualized and based on a thorough pain analysis with investigation of the pain modality, localization and pain intensity. Other factors to consider are the underlying rheumatic disease and treatment, the patient's mental and physical health status and psychological factors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arthritis; Biologic; Cognitive; Inflammation; JAK-inhibitor; Pain; Pain sensitization; Physical activity; Psoriatic arthritis; Rheumatic

Year:  2019        PMID: 31703790     DOI: 10.1016/j.berh.2019.101439

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  7 in total

Review 1.  Interaction of pain and chronic inflammation.

Authors:  O Seifert; C Baerwald
Journal:  Z Rheumatol       Date:  2020-12-29       Impact factor: 1.372

Review 2.  [Pain in rheumatic diseases : What can biologics and JAK inhibitors offer?]

Authors:  G Pongratz
Journal:  Z Rheumatol       Date:  2021-01-14       Impact factor: 1.372

3.  Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.

Authors:  Mateusz Wilk; Katarzyna Łosińska; Are H Pripp; Mariusz Korkosz; Glenn Haugeberg
Journal:  Rheumatol Int       Date:  2022-01-31       Impact factor: 2.631

Review 4.  ATP transporters in the joints.

Authors:  Ane Larrañaga-Vera; Miguel Marco-Bonilla; Raquel Largo; Gabriel Herrero-Beaumont; Aránzazu Mediero; Bruce Cronstein
Journal:  Purinergic Signal       Date:  2021-08-15       Impact factor: 3.765

5.  Unmet Needs in Rheumatoid Arthritis: A Subgroup of Patients With High Levels of Pain, Fatigue, and Psychosocial Distress 3 Years After Diagnosis.

Authors:  Joakim Lindqvist; Lars Alfredsson; Lars Klareskog; Jon Lampa; Helga Westerlind
Journal:  ACR Open Rheumatol       Date:  2022-03-09

6.  Generalized pain hypersensitivity and associated factors in gout.

Authors:  Peter M Ten Klooster; Jannis T Kraiss; Rik Munters; Harald E Vonkeman
Journal:  Rheumatology (Oxford)       Date:  2022-08-30       Impact factor: 7.046

7.  Distinct aberrations in cerebral pain processing differentiating patients with fibromyalgia from patients with rheumatoid arthritis.

Authors:  Angelica Sandström; Isabel Ellerbrock; Monika Löfgren; Reem Altawil; Indre Bileviciute-Ljungar; Jon Lampa; Eva Kosek
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.